WesBanco Bank’s Neurocrine Biosciences NBIX Stock Holding History

WesBanco Bank’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.87M	Hold	17,000	–	–	0.07%	202
2026 Q1	$2.24M	Hold	17,000	–	–	0.06%	222
2025 Q4	$2.41M	Buy	17,000 +8,000	+89%	+$1.16M	0.07%	204
2025 Q3	$1.26M	Buy	+9,000	New	+$1.22M	0.04%	332
2015 Q3	–	Sell	-5,500	Closed	-$263K	–	509
2015 Q2	$263K	Hold	5,500	–	–	0.01%	441
2015 Q1	$218K	Buy	+5,500	New	+$197K	0.01%	487
2013 Q4	–	Sell	-16,000	Closed	-$181K	–	528
2013 Q3	$181K	Buy	+16,000	New	+$220K	0.01%	489

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

WesBanco Bank's NBIX Position: Q2 2026 in Review

WesBanco Bank held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 17,000 shares worth $2.87M. The position accounts for 0.07% of the portfolio, ranked #202.

WesBanco Bank first reported a position in NBIX in Q3 2013 and has held it in 7 quarters since. 385 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

WesBanco Bank held 17,000 shares of Neurocrine Biosciences worth $2.87M as of Q2 2026.
WesBanco Bank left its Neurocrine Biosciences share count unchanged in Q2 2026.
Neurocrine Biosciences made up 0.07% of WesBanco Bank's portfolio in Q2 2026, its #202 holding.
WesBanco Bank first reported a position in Neurocrine Biosciences in Q3 2013 and has held it in 7 quarters since.
385 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.